About NRI Commericial

At this writing, NRI is currently finalizing a first spin-out centered on one of its user interface technologies.

Resultant from years of extensive research and development, NRI has a number of other patent-protected technologies and innovations that appear well-suited for commercialization. Separate commercial divisions have been established within NRI for several of these. Currently active commercial divisions include:

  • Reconfigurable Lab-on-a-chip (RLOC)
  • Image Focus Correction (ICF)
  • Fractional Fourier Optical Processors (FFOP)
  • Electronic Musical Instruments (EMI)
  • New Signal Processing (NSP)
  • Molecular and Nano-Electronics

NRI is prepared to license these technologies, as well as to partner, spin-out, or sell these commercial divisions as stand-alone companies.

While NRI is actively pursuing both further R&D and commercial opportunities for these divisions, it is continuing R&D and pre-commercialization preparatory work in a number of other technology areas. Additional technology commercialization divisions will continue to be announced.

For further information, please contact Lisa Negele, CEO Commercial Divisions lnegele@nri-commercial.com

Lisa Negele, CEO Commercial Divisions
Ms. Negele has successfully launched a number of businesses in a variety of technical and transactional industries. Ms. Negele holds a joint bachelors degree in Economics and Mathematics from U.C. Berkeley and has an extensive record as an entrepreneur and as CEO.

New Renaissance Institute® technology transfer activities relating to fractional-order mathematics, systems, and processes in electronics and other engineering areas are undertaken within its subsidiary FractionalOrder® (www.fractionalorder.com, inquiries@fractionalorder.com).